
Join to view full profile
330 Brookline AveBoston, MA 02215
Phone+1 617-677-7000
Fax+1 617-667-8665
Dr. Carney is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am an attending physician in the Division of Hematology and Hematologic Malignancies at Beth Israel Deaconess Medical Center and an Assistant Professor of Medicine at Harvard Medical School. The focus of my research is cancer-associated thrombosis, particularly anticoagulation management in patients at high risk for hemorrhage.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2016 - 2019
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2013 - 2016
Tufts University School of MedicineClass of 2013
Providence CollegeClass of 2009
Certifications & Licensure
MA State Medical License 2013 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- BRIDGE-2M: Optimizing Bridging Therapy Prior to CAR-T Therapy in Multiple Myeloma: A Modified Double-Blind Delphi Panel of US Physicians.Rahul Banerjee, Hamza Hashmi, Preet M Chaudhary, Shebli Atrash, Kimberly Green
Advances in Therapy. 2026-08-19 - Therapeutic Plasma Exchange for Removal of Bevacizumab: A Case Series.Sooraj Srirangadhamu Gopu, Rushad Patell, Erik J Uhlmann, Rafael A Vega, Brian J Carney
Journal of Clinical Apheresis. 2026-08-01 - Intracranial hemorrhage in patients with primary brain cancer receiving anticoagulation.Eva N Hamulyák, Tzu-Fei Wang, Lisa Baumann Kreuziger, Varun Iyengar, Brian J Carney
Blood Vessels, Thrombosis & Hemostasis. 2026-05-01
Lectures
- Recurrent intracranial hemorrhage and venous thromboembolism following initial intracranial hemorrhage in patients with brain tumors on anticoagulation61st Annual American Society of Hematology Meeting - Orlando, FL - 12/8/2019
- Safety of direct-acting oral anticoagulants vs. enoxaparin in patients with primary and metastatic brain tumors60th Annual American Society of Hematology Meeting - San Diego, CA - 12/2/2018
Press Mentions
Sickle Cell Trait Widely Misinterpreted as Cause of DeathFebruary 12th, 2025
Modified-Dose Anticoagulation in Patients with Cancer, VTE, and ThrombocytopeniaDecember 1st, 2021
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









